Literature DB >> 2362892

Repeated echocardiography: essential in the management of Staphylococcus aureus endocarditis.

J J O'Sullivan1, T Aherne, J Erwin.   

Abstract

Staphylococcus aureus endocarditis in a previously healthy 25 year old man is described. Repeated echocardiography recorded rapid progression of aortic root and interventricular septal involvement and, even though the patient was clinically stable, early surgery was advised with a satisfactory outcome. This case report clearly demonstrates the vital role of repeated cross-sectional echocardiography in the management of such cases.

Entities:  

Mesh:

Year:  1990        PMID: 2362892      PMCID: PMC2429457          DOI: 10.1136/pgmj.66.773.227

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Staphylococcal bacteremia and endocarditis: state of the art.

Authors:  A S Bayer
Journal:  Arch Intern Med       Date:  1982-06

2.  The challenge and the reproach of infective endocarditis.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1985-08

3.  Vegetations in infective endocarditis. Clinical relevance and diagnosis by cross sectional echocardiography.

Authors:  W J Stafford; J Petch; D J Radford
Journal:  Br Heart J       Date:  1985-03

4.  Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.

Authors:  H F Chambers; O M Korzeniowski; M A Sande
Journal:  Medicine (Baltimore)       Date:  1983-05       Impact factor: 1.889

5.  Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers.

Authors:  B Abrams; A Sklaver; T Hoffman; R Greenman
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

6.  Treatment of infective endocarditis: a 10-year comparative analysis.

Authors:  J V Richardson; R B Karp; J W Kirklin; W E Dismukes
Journal:  Circulation       Date:  1978-10       Impact factor: 29.690

Review 7.  Staphylococcal infective endocarditis.

Authors:  R L Thompson
Journal:  Mayo Clin Proc       Date:  1982-02       Impact factor: 7.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.